TransMedics (TMDX) Convertible Debt (2023 - 2026)

TransMedics has reported Convertible Debt for 4 years, with the latest figure at $453.5 million in Q1 2026.

• For the quarter ending Q1 2026, Convertible Debt rose 0.64% year-over-year to $453.5 million; the trailing twelve-month figure through Mar 2026 stood at $453.5 million (up 0.64% YoY), and the FY2025 full-year result was $452.8 million, up 0.64% from the prior year.
• Convertible Debt for Q1 2026 stood at $453.5 million, roughly flat from $452.8 million in the prior quarter.
• The five-year high for Convertible Debt was $453.5 million in Q1 2026, with the low at $445.8 million in Q2 2023.
• Average Convertible Debt over 4 years is $449.6 million, with a median of $449.6 million recorded in 2024.
• Year-over-year, Convertible Debt climbed 0.62% in 2024 and grew 0.64% in 2026.
• Tracing TMDX's Convertible Debt over 4 years: stood at $447.1 million in 2023, then increased by 0.63% to $449.9 million in 2024, then advanced by 0.64% to $452.8 million in 2025, then increased by 0.16% to $453.5 million in 2026.
• The last three Convertible Debt figures came in at $453.5 million (Q1 2026), $452.8 million (Q4 2025), and $452.1 million (Q3 2025), per Business Quant data.

Peer Comparison